




































































Transposase coding sequences 
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Supplementary	   Figure	   1.	   DNA	   sequences.	   The	   complete	   DNA	   sequence	   of	   the	   consensus	   Helibat1	   (Helraiser)	   transposon,	   and	   the	  
consensus	   left	   terminal	   and	   right	   terminal	   sequences	   of	   autonomous	   and	   non-­‐autonomous	   transposons	   that	   were	   used	   in	   the	  











Supplementary	  Figure	  2.	  Protein	  sequence	  alignment	  and	  domain	  mapping.	  A)	  Overall	  protein	  sequence	  alignment	  of	  Helraiser	  from	  
M.	  lucifugus	  with	  Helitron	  transposase	  sequences	  from	  C.	  elegans,	  T.	  castaneum,	  P.	  infestans,	  L.	  corymbifera,	  A.	  thaliana	  and	  O.	  sativa.	  
Secondary	   structural	   features	   show	   beta	   strands	   as	   arrows	   and	   helices	   as	   spirals.	   The	   domains	   determined	   by	   trypsin	   digest	   are	  
represented	  as	  colored	  bars	  below	  the	  sequence.	  Predicted	  nuclear	  localization	  signal	  and	  zinc-­‐finger	  motifs	  are	  indicated	  by	  orange	  and	  
violet	  bars	  below	  the	  sequence,	   respectively.	  Mutated	  catalytic	   residues	  are	  highlighted	   in	  blue,	  helicase	  motifs	   in	  cyan	  and	   identical	  
residues	  in	  red.	  B)	  SDS-­‐PAGE	  analysis	  of	  the	  purified	  Helraiser	  digest	  by	  increasing	  amounts	  of	  trypsin.	  N-­‐terminal	  sequencing	  identified	  
the	  helicase	  fragment	  encompassing	  the	  amino	  acids	  811-­‐1496,	  HUH	  nuclease	  fragment	  containing	  amino	  acids	  491-­‐745	  and	  N-­‐terminal	  

















Supplementary	  Figure	  3.	  Structural	  and	  functional	  properties	  of	  Helraiser	  transposase	  domains.	  The	  Helraiser	  helicase	  domain	  aligns	  
with	   the	   SF1B	   subfamily	   group	   members	   and	   is	   closely	   related	   to	   Pif1	   helicases,	   a	   family	   of	   helicases	   involved	   in	   homologous	  
recombination	   and	   the	   resolution	   of	   stalled	   replication	   forks1,	   2,	   3,	   a	   previously	   noted	   feature	   of	   Helitrons4.	   A)	   Helicase	   sequence	  
alignment.	  Top:	  ribbon	  models	  of	  RecD	  helicase	  from	  E.	  coli,	  Helitron	  helicase	  and	  PcrA	  helicase	  from	  G.	  stearothermophilus	  are	  shown	  
in	  green,	  purple	  and	  cyan,	  respectively.	  The	  four	  domains	  of	  each	  helicase	  are	  labeled.	  Bottom:	  overall	  protein	  sequence	  alignment	  of	  
Helitron	  helicases	  from	  M.	  lucifugus	  (Helraiser),	  A.	  thaliana	  and	  O.	  sativa	  with	  SF1B	  helicases	  [(Pif1	  (S.	  cerevisiae),	  Dna2	  (S.	  cerevisiae),	  
Dda	  (E.	  phage	  T4),	  TraI	  (E.	  coli)	  and	  RecD	  (E.	  coli)]	  on	  the	  left	  and	  SF1A	  helicases	  [Rep	  (E.coli),	  UvrD	  (B.	  subtilis	  ssp.	  subtilis	  str.	  168)	  and	  
PcrA	  (G.	  stearothermophilus)]	  on	  the	  rigt.	  Secondary	  structural	   features	  show	  beta	  sheets	  as	  arrows	  and	  helices	  as	  spirals.	  Conserved	  
SF1	  helicase	  motifs	  are	  highlighted	  in	  red.	  B)	  In	  vitro	  cleavage	  ssDNA	  of	  5’-­‐	  or	  3’-­‐terminus	  top	  and	  bottom	  strand.	  15%	  TBE-­‐UREA	  gel	  of	  
5’	  FAM-­‐labeled	  oligonucleotides	  cleavage	  by	  Helraiser	  transposase.	  Schematic	  of	  DNA	  on	  the	  right	  depicts	  the	  four	  ssDNA	  substrates,	  5’-­‐	  
and	  3’-­‐terminus	  sequence	  is	  in	  bold,	  flanking	  sequence	  in	  regular	  script,	  and	  3’-­‐hairpin	  is	  underlined.	  The	  red	  arrows	  show	  the	  cleavage	  





Supplementary	  Figure	  4.	  Examples	  of	  diversification	  of	  3’-­‐ends	  of	  Helitrons	  in	  Myotis	  genomes.	  A)	  Acquisition	  of	  a	  novel	  Helitron	  end.	  
Insertion	  of	  a	  Helitron	  copy	  adjacent	  to	  a	  Helitron	  with	  truncated	  5’-­‐end	  can	  lead	  to	  acquisition	  of	  a	  novel	  3’-­‐end.	  B)	  Insertion	  of	  Helitron	  
right	  next	  to	  each	  other.	  Insertion	  of	  a	  Helitron	  between	  5’-­‐A	  of	  the	  host	  and	  T-­‐3’	  of	  a	  Helitron	  can	  result	  in	  insertions,	  where	  a	  3’-­‐end	  of	  
one	   Helitron	   abuts	   the	   5’-­‐end	   of	   another	   Helitron.	   C)	   Generation	   of	   a	   de	   novo	   end,	   possibly	   by	   the	   truncation	   of	   the	   3’-­‐end.	   D)	  
Comparison	  of	  host	  sequences	  with	  Helitron	  insertions	  (described	  from	  A-­‐C)	  and	  the	  orthologous	  empty	  (insertion-­‐free)	  sites.	  The	  first	  
line	  is	  the	  host	  sequence	  flanking	  the	  Helitron	  insertion.	  The	  second	  line	  is	  the	  orthologous	  empty	  site.	  The	  sequences	  in	  black	  represent	  
the	  host	  sequence	  and	  sequence	  in	  green	  represents	  the	  Helitron	  sequences.	  The	  accession	  number	  and	  coordinates	  are	  shown	  in	  black.	  
E)	  Generation	  of	  de	  novo	   termini	  by	  end-­‐bypass	   [i]	  The	   top	  cartoon	  shows	  the	  structure	  of	   the	  HelibatN542	   consensus.	  The	   terminal	  
sequence	  of	  the	  consensus	  is	  shown	  adjacent	  to	  the	  cartoon.	  The	  palindrome	  within	  the	  terminus	  is	  shown	  in	  purple	  and	  sequences	  that	  
comprise	   the	   stem	  of	   the	  palindrome	  are	  underlined.	   [ii]	   Cartoon	   representation	  of	   the	   structure	  of	   a	  HelibatN542	   copy	   lacking	   the	  
palindromic	  sequence,	  resulting	  in	  a	  different	  3’-­‐end.	  The	  sequence	  of	  the	  novel	  3’-­‐end	  is	  shown	  next	  to	  the	  cartoon.	  [iii]	  Location	  of	  the	  
two	  HelibatN542	  copies	  in	  the	  genome.	  The	  transposition	  of	  one	  copy	  (shown	  as	  black	  dashed	  lines)	  resulted	  in	  end-­‐bypass	  of	  the	  CTAG-­‐
3’	  terminus	  and	  terminated	  at	  a	  random	  sequence	  followed	  by	  a	  short	  palindrome.	  The	  copy	  was	  then	  inserted	  to	  a	  different	  position	  
(red	  line)	  in	  the	  genome.	  The	  novel	  terminal	  sequence	  including	  the	  palindrome	  is	  shown	  next	  to	  the	  cartoon.	  [iv]	  The	  first	   line	  is	  the	  
host	   sequence	  with	   the	  Helitron	   insertion	  and	   the	  novel	   terminus.	   The	   second	   line	   is	   the	  paralogous	   copy	  with	   the	  Helitron	   and	   the	  
novel	   terminus.	  The	  sequences	   in	  black	   represent	   the	   flanking	  host	  sequence	  and	  sequence	   in	  green	  represents	   the	  Helitron	  and	   the	  
captured	  host	  sequences.	  The	  accession	  number	  and	  coordinates	  are	  shown	  in	  black.	   
 
Supplementary	  Figure	  5.	  RINT1,	  ARMC9	  and	  RNF10	   loci	  (M.	  brandtii).	  A)	  RINT1	   locus.	  B)	  ARMC9	   locus.	  C)	  RNF10	   locus.	  Shown	  at	  the	  
top	   of	   each	   panel	   is	   an	   IGV	   genome	   browser	   snapshot	   of	   the	   full	   gene	   models	   determined	   by	   our	   transcriptome	   assembly	   (only	  
transcript	  assemblies	  with	  FPKM	  >0.5	  shown).	  The	  expanded	  versions	  represent	  the	  regions	  of	  the	  gene	  models	  that	  contain	  the	  NUBPL-­‐
driven	  transcripts.	  In	  the	  expanded	  versions,	  the	  top	  tracks	  represent	  the	  total	  coverage	  of	  the	  RNA-­‐seq	  reads	  for	  the	  gene	  models,	  the	  
tracks	   below	   show	  a	   subset	   of	   the	   reads	   aligning	   to	   the	   regions.	   The	   third	   tracks	   indicate	   the	   locations	   of	   repeats	   and	   transposable	  
elements	  (blue),	  as	  well	  as	  the	  locations	  of	  the	  NUBPL	  fragments	  (yellow).	  The	  bottom	  tracks	  contain	  the	  transcript	  assemblies	  (FPKM	  















Supplementary	  Table	  1.	  Contingency	  Count	  Table	  for	  Helitron	  enrichment	  analyses	  in	  +/-­‐1	  kb	  regions	  around	  TSSs	  in	  M.	  brandtii.	  
	  
*	   #	  of	  times	  Helitrons	  overlap	  with	  +/-­‐1	  kb	  regions	  around	  TSSs	  
ⱡ	  	   #	  of	  +/-­‐1	  kb	  regions	  around	  TSSs	  that	  do	  not	  overlap	  with	  Helitrons	  	  
 	  	   #	  of	  Helitrons	  that	  do	  not	  overlap	  with	  +/-­‐1	  kb	  regions	  around	  TSSs	  
+	  	   #	  of	  regions	  (estimated)	  that	  do	  not	  overlap	  with	  either	  Helitrons	  or	  +/-­‐1	  kb	  regions	  around	  TSSs	  
°	  	   Left	  	  p-­‐values	  indicate	  probability	  of	  Helitrons	  being	  depleted	  in	  +/-­‐1	  kb	  regions	  around	  TSSs.	  Right	  p-­‐values	  indicate	  the	  
	   probability	  of	  enrichment,	  and	  Two-­‐Tailed	  the	  probability	  of	  Helitrons	  being	  different	  than	  what	  is	  expected	  by	  chance.	  
	   	   In	  +/-­	  1	  kb	  TSS	   Outside	  +/-­1	  kb	  TSS	   p-­value	  (Fisher’s	  exact)°	  
All	  Helitrons	   In	  Helitrons	   2455*	   495356	  
#	  insertions:	  497811	  
#	  genes:	  8829	   Outside	  Helitrons	   6374ⱡ	   444254+	   Left:	  p	  =	  0	  Right:	  p	  =	  1	  Two-­tailed:	  p	  =	  0	  	   In	  +/-­	  1	  kb	  TSS	   Outside	  +/-­1	  kb	  TSS	   p-­value	  (Fisher’s	  exact)°	  
Helitrons	  w/	  gene	  
captures	  
In	  Helitrons	   643*	   95878	  
#	  insertions:	  96521	  
#	  genes:	  8829	   Outside	  Helitrons	   8186	  ⱡ	   861384+	  
Left:	  p	  =	  3.16e-­‐19	  
Right:	  p	  =	  1	  






































Supplementary	   Table	   3.	   Candidate	   NUBPL-­‐driven	   transcripts.	   This	   table	   lists	   the	   information	   for	   each	   candidate	   NUBPL-­‐driven	  
transcript	   including	   its	   ID,	   the	   name	   of	   the	   gene	   it	   belongs	   to,	   the	   scaffold	   and	   coordinates	   of	   the	   transcript,	   and	   its	   tissue-­‐specific	  
expression,	  if	  any.	  The	  information	  about	  the	  specific	  NUBPL	  promoter	  insertion	  is	  listed	  on	  the	  right	  side	  of	  the	  table,	  and	  includes	  the	  
donor	  Helitron	  element,	  the	  distance	  of	  the	  element	  from	  the	  TSS	  (annotated	  based	  on	  our	  transcriptome	  assembly;	  positive	  number	  
indicates	  that	  it	  overlaps	  the	  TSS),	  and	  its	  approximate	  age,	  determined	  as	  described	  in	  Methods.	  Transcripts	  labeled	  in	  green	  are	  those	  
whose	   TSS	   is	   donated	   by	   the	  NUBPL-­‐promoter	   containing	   insertion.	   The	   numbers	   1	   and	   2	   indicate	   the	   orientation	   of	   the	   transcript.	  
Transcripts	  denoted	  with	  a	  1	  are	  driven	   in	   the	  canonical	  direction	  by	  the	  NUBPL	  promoter,	  whereas	   transcripts	  denoted	  with	  a	  2	  are	  
driven	  in	  the	  reverse	  direction.	  Many	  (11)	  of	  these	  insertions	  are	  present	  in	  the	  genomes	  of	  the	  other	  three	  sequenced	  vespertilionid	  
bats	  (M.	  lucifugus,	  M.	  davidii,	  Eptesicus	  fuscus),	  but	  there	  are	  several	  (12)	  lineage-­‐specific	  insertions,	  including	  those	  in	  the	  FOXJ2	  and	  
STX10	   genes	   that	   are	   specific	   to	  M.	   brandtii,	   consistent	   with	   Helibat	   activity	   throughout	   the	   diversification	   of	   vesper	   bats5.	   Nine	  
insertions	  appear	  to	  drive	  their	  transcripts	  in	  the	  canonical	  direction,	  whereas	  eight	  insertions	  drive	  transcripts	  in	  the	  reverse	  direction,	  
suggesting	   that	   the	   captured	   NUBPL	   promoter	   is	   bi-­‐directional.	   This	   is	   further	   supported	   by	   the	   presence	   of	   many	   characteristic	  
promoter	  sequence	  features	  (TATA,	  CAAT,	  and	  GC	  boxes	  as	  well	  as	  predicted	  TF	  binding	  sites/overrepresented	  sites)	  on	  both	  strands	  of	  
the	  captured	  promoter	  sequence	   (data	  not	  shown).	   In	  spite	  of	   the	  small	   set,	   these	  genes	  are	  enriched	   for	  several	  GO	  Terms:	  protein	  
ubiquitination	   (GO:	   0016567;	   p=1.295e-­‐02),	   regulation	   of	   signal	   transduction	   involved	   in	   mitotic	   G2	   DNA	   damage	   checkpoint	   (GO:	  
1902504;	   p=1.481e-­‐02),	   protein	  modification	   by	   small	   protein	   conjugation	   (GO:	   0032446;	   p=1.66e-­‐02),	   protein	  modification	   by	   small	  
protein	   conjugation	   or	   removal	   (GO:	   0070647;	   p=3.104e-­‐02),	   organelle	   organization	   (GO:	   0006996;	   p=3.312e-­‐02),	   cell	   cycle	   (GO:	  
0007049;	  p=4.082e-­‐02),	  and	  actin	  polymerization-­‐dependent	  cell	  motility	  (GO:	  0070358;	  p=4.439e-­‐02).	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Hemispecific primers for 
fusion transcript detection 
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTSVVNNNTGTA 
First Y to Phe* GCCTCCATCAAATCCGTGAAGTTCCTGTTCAAATACATCTACAAAGGC 
Second Y to Phe* GTGAAGTACCTGTTCAAATTTATCTACAAAGGCCACGACTGC 
Double H to Ala* CAGAAACGGGGCCTGCCAGCAGCCGCAATCCTGCTGATCCTGG 
Double H to Gln* CAGAAACGGGGCCTGCCACAAGCCCAAATCCTGCTGATCCTGG 
Double Y to Phe* GCCTCCATCAAATCCGTGAAGTTCCTGTTCAAATTTATCTACAAAGGC 
Helicase K1068Q* GGACCCGGAGGGTCTGGCCAAACCTACCTGTATAAAGTG 
Helicase R1457Q* CTGTATGTGGCCTTTAGCCAAGTGCGCCGGGCCTGCGAT 
HUH NcoI site* GATAATGTGCCGATTGGCACCATGGTTATTCTGCCGAGCAGTTTTG 
HUH stop one* CAGATTAGCGAAAAAAACTGAATCAACCACGATGAGGTG 
First Y to Phe-insect* GCCAGCATTAAAAGCGTGAAATTCCTGTTCAAATATATCTATAAAGGC 
Second Y to Phe-insect* GTGAAATACCTGTTCAAATTTATCTATAAAGGCCACGATTGC 
Double H to Ala-insect* CAGAAACGGGGCCTGCCAGCAGCCGCAATCCTGCTGATCCTGG 
Double H to Gln-insect* CAGAAACGTGGTCTGCCGCAAGCCCAAATTCTGCTGATTCTGG 
Double Y to Phe-insect* GCCAGCATTAAAAGCGTGAAATTCCTGTTCAAATTTATCTATAAAGGC 
Helicase K1068Q-insect* GGTCCGGGTGGCAGCGGTAACACCTATCTGTATAAAGTG 
Helicase  R1457Q-insect* CTGTACGTTGCCTTTAGCAACGTTCGTCGTGCATGTGAT 
Helraiser LTS substrate 
(+)* CACCATATGATCCTATATAATAAAAGAGAAACATGCAAATTGACCATCCC 
Helraiser RTS substrate 
(+)* CCCTTTCAATGTGCACGAATTTCGTGCACCGGGCCACTAGTATATATATA 
HelMut fwd* CCCTTTCAATGTGCACGAA CGGGCCACTAGTATATATATAAAGC 

















SX fwd AATTTCCGCAGGTCGGGCCAC 




Linker primer GTAATACGACTCACTATAGGGC 











HA tag top gactctactagtgccaccATGTACCCTTACGACGTACCGGATTACGCC 
TACCCTTACGACGTACCGGATTACGCCactagtgactct 
HA tag bottom agagtcactagtGGCGTAATCCGGTACGTCGTAAGGGTAGGCGTAATC 
CGGTACGTCGTAAGGGTACATggtggcactagtagagtc 
Universal primer for the 
ssDNA LM-PCR 
CGCTGGAAGCTTAAG 
5+ primer for the  ssDNA 
LM-PCR 
GCGCGGGAATTCCACCATATG 
5- primer for the  ssDNA 
LM-PCR 
GCGCGGGAATTCGGGATGGTCAATTTGC 
3+ primer for the  ssDNA 
LM-PCR 
GCGCGGGAATTCCCCTTTCAATGTGCACG 





Supplementary	  Table	  4.	  List	  of	  primers.	  For	  primer	  pairs	  where	  reverse	  primer	  is	  reverse	  complement	  of	  the	  forward	  primer	  sequence,	  




Supplementary	  Note	  1	  
Molecular	  reconstruction	  of	  the	  Helraiser	  transposon 
Using	  a	   set	  of	  ~300-­‐aa	  protein	   sequences	   corresponding	   to	   the	  conserved	   rolling-­‐circle	   replication	   initiator	  domain	   (Rep)	  
present	   in	   the	   RepHel	   proteins	   encoded	   by	   diverse	   known	   Helitrons	   in	   plants	   and	   metazoans,	   we	   identified	   all	   bat	  
sequences	   coding	   for	   this	   domain	   by	   using	   them	   as	   queries	   in	   a	   Censor6	   search	   against	   the	   GenBank	  Myotis	   lucifugus	  
assembly.	  To	  check	  if	  the	  identified	  DNA	  sequences	  might	  have	  been	  composed	  from	  different	  families,	  we	  performed	  their	  
clustering	   by	   BLASTCLUST	   (standalone	   Blast,	   NCBI).	   Based	   on	   the	   clustering	   results,	   we	   concluded	   that	   the	   bat	   genome	  
contained	  only	  one	  major	  family	  of	  autonomous-­‐like	  Helitrons.	  All	  these	  sequences,	  even	  those	  contaminated	  by	  premature	  
stop	  codons	  and	  short	  indels,	  have	  been	  used	  to	  derive	  a	  ~900-­‐bp	  Rep	  consensus	  sequence	  coding	  for	  the	  catalytic	  domain.	  
At	  the	  next	  step,	  genomic	  sequences	  >90%	  identical	  to	  the	  200-­‐bp	  5’-­‐	  and	  3’-­‐terminal	  parts	  of	  the	  Rep	  consensus	  have	  been	  
expanded	  up	  to	  2	  kb	  upstream	  and	  downstream	  of	  the	  termini,	  respectively.	  For	  the	  two	  sets	  of	  multiple	  alignments	  of	  the	  
expanded	  sequences	  two	  consensus	  sequences	  were	  derived.	  These	  two	  terminal	  consensuses	  and	  the	  Rep	  consensus	  have	  
been	  assembled	  together	  into	  one	  long	  expanded	  consensus.	  This	  procedure	  has	  been	  iteratively	  repeated	  till	  both	  ends	  of	  
the	  bat	  autonomous-­‐like	  Helitron	  have	  been	   identified,	  and	   the	   first	  version	  of	   the	  autonomous	  bat	  consensus	  sequence	  
(Helitron-­‐1_ML)	  was	  built.	  	  
	   Next,	   by	   using	   Censor,	  we	   collected	   all	   copies	   in	   the	  M.	   lucifugus	   genome	   >90%	   identical	   to	   the	  Helitron-­‐1_ML.	  
Based	  on	  the	  pairwise	  alignment	  of	  the	  collected	  sequences	  expanded	  1	  kb	  in	  both	  directions,	  we	  removed	  all	  copies	  that	  
were	  generated	  by	   long	  segmental	  duplications	  (>90	  %	   identical	   to	  each	  other)	  unrelated	  directly	  to	  the	  multiplication	  of	  
Helitrons	  by	  their	  transposition.	  As	  a	  result	  we	  collected	  a	  final	  set	  composed	  of	  500	  copies	  of	  Helitron-­‐1_ML.	  After	  multiple	  
alignment	  of	   all	   these	   sequences	  and	  Helitron-­‐1_ML,	  we	  derived	  a	   second	  version	  of	   the	   consensus,	   a	  5301-­‐bp	  Helitron-­‐
1a_ML	  coding	  for	  a	  1458-­‐aa	  RepHel	  protein	  and	  ~95	  %	  identical	  to	  the	  collected	  500	  copies. 
	   The	  consecutive	  analysis	  of	  the	  Helitron-­‐1a_ML	  copies	  revealed	  that	  the	  genome	  contains	  only	  a	  small	  number	  of	  
autonomous-­‐like	  copies,	  when	  the	  majority	  of	  the	  copies	  are	  in	  fact	  copies	  of	  two	  non-­‐autonomous	  Helitron-­‐1N1_ML	  and	  
Helitron-­‐2N2_ML	  transposons.	  The	  2437-­‐bp	  Helitron-­‐1N1_ML	  and	  2144-­‐bp	  Helitron-­‐1N2_ML	  consensus	  sequences	  encoded	  
the	   610-­‐aa	   N-­‐terminal	   and	   390-­‐aa	   C-­‐terminal	   portions	   of	   the	  Helitron-­‐1a_ML	   RepHel	   protein,	   respectively.	   Presumably,	  
these	  non-­‐autonomous	  transposons	  were	  transposed	  by	  the	  RepHel	  transposase	  expressed	  by	  some	  autonomous	  Helitrons.	  
Therefore,	  we	  concluded	  that	  the	  regions	  in	  the	  non-­‐autonomous	  transposons	  coding	  for	  remnants	  of	  RepHel	  may	  contain	  
mutations	  that	  can	  destroy	  or	  damage	  proper	  functions	  of	  the	  protein	  reconstructed	  from	  copies	  of	  the	  non-­‐autonomous	  
elements.	  To	  avoid	  this	  problem,	  copies	  of	  the	  non-­‐autonomous	  transposons	  were	  excluded	  from	  the	  “500-­‐fragments”	  set.	  
As	  a	  result,	  only	  46	  sequences,	  supposedly	  fragments	  of	  the	  real	  autonomous	  Helitron,	  have	  remained	  in	  the	  modified	  set.	  
Based	  on	  re-­‐alignment	  of	  the	  Helitron-­‐1a_ML	  consensus	  sequence	  with	  these	  46	  sequences,	  a	  new	  5295-­‐bp	  Helitron-­‐1b_ML	  
consensus	   sequence	   encoding	   the	   1494-­‐aa	   RepHel	   protein	   was	   derived	   (~95	   %	   identity	   between	   the	   consensus	   and	   46	  
sequences).	   
	   At	   this	   point	   Helitron-­‐1b_ML	   and	  Helitron-­‐1a_ML	   consensus	   sequences	   were	   98.81	   %	   identical	   and	   the	   RepHel	  
proteins	   encoded	   by	   these	   consensus	   sequences	   differed	   from	   each	   other	   by	   13	   aa	   replacements	   and	   by	   a	   36-­‐aa	   C-­‐tail	  
added	  to	  the	  Helitron-­‐1b_ML	  coding	  sequence. 
	   Since	   the	   sequences	   in	   the	  original	   “500-­‐fragments”	   set	   have	  not	   contained	   short	   fragment	  of	   long	   autonomous	  
Helitrons	   generated	   by	   insertions	   of	   other	   transposable	   elements	   and	   by	   internal	   deletions,	   for	   each	   of	   the	   46	   coding	  
sequences	   the	   Helitron-­‐1b_ML	   was	   derived	   from,	   all	   terminal	   and	   additional	   internal	   fragments	   were	   manually	   added	  
creating	  thereby	  a	  set	  of	  177	  fragments.	  Based	  on	  re-­‐alignment	  of	  the	  Helitron-­‐1b_ML	  consensus	  with	  all	  these	  fragments,	  
the	   final	  version	  of	   the	  5296-­‐bp	  autonomous	  consensus	  sequence	   that	  we	  named	  Helraiser	  was	  derived	   (Supplementary 
Fig.	  1).	  	  
	  
Supplementary	  Note	  2	  
Constructs	  
Transposase	  vectors.	  The	  coding	  region	  of	  the	  Helraiser	  transposase	  was	  synthesized	  by	  GenScript	  following	  human	  codon	  
optimization,	  and	  cloned	  by	  SpeI/XhoI	  into	  the	  expression	  vector	  FV4a7	  to	  yield	  the	  transposase	  helper	  plasmid	  pFHelR.	  An	  
N-­‐terminal	  2XHA-­‐tag	  was	  inserted	  as	  a	  synthetic	  double-­‐stranded	  oligonucleotide	  encoding	  MYPYDVPDYAYPYDVPDYA	  into	  
the	   SpeI	   site	   of	   pFHelR	   to	   yield	   pF-­‐HA-­‐HelR.	   The	   CMV	   promoter-­‐driven	   transposase	   expression	   plasmid	   pCHelR	   was	  
generated	  by	  inserting	  the	  SpeI/XhoI	  fragment	  of	  pFHelR	  into	  the	  NheI/XhoI	  sites	  of	  pcDNA3.1(-­‐)	  (Invitrogen).	  To	  create	  the	  
pCHelRGFP	  plasmid,	  the	  XhoI/NotI	  fragment	  of	  pMSCV20Ires-­‐GFP	  (from	  B.	  Schroeder,	  MDC)	  was	  inserted	  into	  the	  XhoI/NotI	  
sites	   of	   pCHelR.	   Transposase	   catalytic	  mutant	   expression	   plasmids	  were	   generated	   by	  mutagenic	   PCR	   using	   pCHelR	   as	   a	  
template.	   The	   transposase	   vector	   used	   for	  Helraiser	   protein	   expression	   in	   insect	   cells	   was	   generated	   by	   subcloning	   the	  
Helraiser	  transposase	  coding	  sequence	  synthesized	  by	  GENEART	  (Invitrogen)	  into	  pFastBac	  HT-­‐A	  (Invitrogen)	  using	  NcoI	  and	  
XhoI	  restriction	  sites.	  
	  
Transposon	   vectors.	   An	   SV40-­‐puro	   or	   SV40-­‐neo	   selection	   cassette	   was	   cloned	   between	   the	   consensus	   LTS	   and	   RTS	  
sequences	  of	  Helibat1	   (pHelR),	  HelibatN1,	  HelibatN2	  and	  HelibatN3	  that	  were	  synthesized	  by	  GeneScript	   (Supplementary 
Fig.	   1).	   Transposon	   donor	   vectors	   pHelRΔHP,	   pHelRMut,	   pHelRATH,	   pHelRStemX	   and	   pHelRLoopX	   were	   generated	   by	  
deletion	   or	   replacement	   of	   the	   palindromic	   sequence	   in	   the	   transposon	   3’-­‐end.	   pHelRMut	   and	   pHelRΔHP	   vectors	   were	  
created	  by	  deletion	  PCR	  using	  primer	  pairs:	  Hel-­‐Mut	  fwd/Hel-­‐Mut	  rev,	  and	  HelRDelH	  fwd	  and	  HelRDelH	  rev,	  respectively.	  To	  
generate	  pHelRATH	  and	  pHelRLoopX	  donor	  plasmids	  four	  oligonucleotides	  ATH1,	  ATH2,	  ATH3,	  ATH4	  and	  LX1,	  LX2,	  LX3,	  LX4,	  
respectively,	  were	  annealed	  in	  equimolar	  ratios	  (0.8	  µM	  each	  oligo,	  0.2	  mM	  dNTP	  mix	  and	  1	  µl	  PfuUltra	  II	  Fusion	  HotStart	  
DNA	  Polymerase	  (Agilent	  technologies)	  /	  50	  µl	   reaction).	  The	  temperature	  profile	   for	  the	  oligo	  annealing	  reaction	  was	  10	  
cycles	  at	  95	  °C	  for	  20	  s,	  72	  °C	  for	  10	  s.	  1	  µl	  of	  the	  annealing	  reaction	  was	  used	  for	  the	  PCR	  amplification	  of	  the	  ATH	  or	  LX	  
fragments	  using	  the	  ATH5/ATH6	  and	  LX5/LX6	  primer	  pairs,	  respectively.	  In	  the	  final	  step,	  ATH	  and	  LX	  PCR	  fragments	  were	  
digested	  by	  SpeI	  and	  BamHI	  and	  cloned	  into	  the	  SpeI/BamHI	  sites	  of	  pHelR.	  To	  generate	  the	  pHelRStemX	  transposon	  donor	  
plasmid,	  pHelRATH	  was	  used	  as	  a	  template	  in	  mutagenesis	  PCR	  together	  with	  the	  primers	  SX	  fwd	  and	  SX	  rev.	  After	  the	  PCR	  
reaction	   the	   ends	   of	   the	   linear	   fragment	   were	   ligated	   together,	   thereby	   generating	   pHelRStemX.	   To	   create	   pHelRΔRTS,	  
pHelR	  was	  digested	  with	  SpeI/BamHI	  restriction	  enzymes.	  The	  restriction	  sites	  were	  blunted	  with	  Klenow	  (Fermentas)	  and	  
re-­‐ligated.	  The	  pHelRΔLTS	  donor	  plasmid	  was	  generated	  through	  NdeI	  and	  EcoRI	  digestion	  of	  the	  Hel1C	  backbone	  followed	  
by	  Klenow	  treatment	  of	  the	  restriction	  sites	  and	  vector	  backbone	  re-­‐ligation.	  The	  pHelRPN	  and	  pHelRΔHPN	  donor	  plasmids	  
were	  generated	  by	  inserting	  the	  SpeI	  fragment	  from	  the	  pUC19SBneo8	  vector	  into	  the	  SpeI	  site	  of	  the	  pHelR	  and	  pHelRΔHP	  
vectors,	  respectively.	  To	  generate	  the	  Helitron	  circle	  donor	  plasmid	  pHelRCD,	  first	  pIRES-­‐EGFP-­‐N1	  vector	  was	  constructed	  by	  
cloning	   the	   NotI/BamHI	   fragment	   of	   pWAS-­‐EGFP	   into	   the	   NotI/BamHI	   sites	   of	   the	   pGFP-­‐N1	   plasmid	   (Clontech).	   The	  
EcoRI/BamHI	   fragment	  of	   the	  pIRES-­‐EGFP-­‐N1	  plasmid	  was	   then	   cloned	   into	   the	  EcoRI/BamHI	   sites	  of	   the	  pHelR	  plasmid,	  
thereby	   creating	  pHelRCD.	  The	  pHelRCneo	  vector	  was	   created	  by	   inserting	   the	  BamHI/EcoRI	   fragment	   from	  pHC	  plasmid	  
(generated	   through	  Helraiser	   transposition	   from	   the	   pHelRCD	   donor	   plasmid	   in	  HeLa	   cells)	   into	   the	  BamHI/MfeI	   sites	   of	  
pcDNA3.1(-­‐).	  In	  the	  next	  step,	  the	  neo	  coding	  sequence	  in	  pHelRCneo	  was	  exchanged	  with	  the	  puro	  coding	  sequence	  from	  
the	  pHel1C	  plasmid	  using	  the	  AvrII/BamHI	  restriction	  sites,	  thereby	  generating	  the	  pHelRCpuro	  vector.	  The	  Helitron	  circle	  
vector	  with	   the	  deletion	  of	   the	  palindromic	   sequence	   in	   the	   transposon	  3’-­‐terminus,	  pHelRCΔHPpuro,	  was	  generated	  via	  
site	  directed	  mutagenesis	  PCR	  using	  pHelRCpuro	  as	  a	  template	  and	  Hel-­‐Mut	  fwd/Hel-­‐Mut	  rev	  primer	  pair.	  The	  integrity	  of	  
all	  coding	  regions	  and	  transposon	  constructs	  generated	  by	  PCR	  was	  verified	  by	  DNA	  sequencing.	  
	  
Supplementary	  Note	  3	  
Circle	  detection	  assay	  
Helraiser	  circle	  formation	  in	  HeLa	  cells	  was	  confirmed	  by	  circle	  detection	  PCR.	  First,	  2	  ×	  105	  HeLa	  cells	  were	  seeded	  onto	  six	  
well	  plates	  one	  day	  prior	  to	  transfection.	  48	  hours	  post-­‐transfection,	  plasmids	  were	  isolated	  from	  the	  cells	  using	  a	  modified	  
Qiagen	  QIAprep	  Spin	  Miniprep	  protocol	  using	  300	  µl	  1.2	  %	  SDS	  supplemented	  with	  50	  μg	  of	  Proteinase	  K	  in	  the	  cell	  lysis	  step	  
instead	   of	   the	   P2	   buffer.	   The	   rest	   of	   the	   plasmid	   isolation	   procedure	   was	   performed	   according	   to	   the	   manufacturer’s	  
protocol.	  150	  ng	  of	  isolated	  plasmid	  was	  used	  for	  PCR	  with	  the	  primers	  Hel1	  and	  Hel5.	  The	  temperature	  profile	  for	  PCR	  was:	  
98	  °C	  for	  2	  min,	  followed	  by	  34	  cycles	  of	  98	  °C	  for	  10	  s,	  59	  °C	  for	  15	  s,	  72	  °C	  for	  10	  s.	  The	  final	  elongation	  was	  performed	  at	  
72	  °C	  for	  5	  min. 
	  
Supplementary	  Note	  4	  
Helraiser	  re-­‐transposition	  in	  HeLa	  cells	  
For	  re-­‐transposition	  assays,	  H1	  cells	  were	  grown	  on	  a	  100-­‐mm	  plate	  (2	  µg/ml	  puromycin)	  until	  confluency.	  One	  day	  prior	  to	  
transfection,	  2	  ×	  106	  cells	  were	  seeded	  onto	  a	  new	  100-­‐mm	  plate.	  Twenty	  µl	  of	  jetPRIME	  transfection	  reagent	  and	  500	  µl	  of	  
jetPRIME	  buffer	  were	  used	  to	  transfect	  3.5	  µg	  of	  pCHelRGFP	  plasmid	  to	  the	  cells.	  Forty-­‐eight	  hours	  after	  transfection,	  cells	  
were	  FACS-­‐sorted	  for	  GFP	  expression	  and	  5	  x	  105	  GFP-­‐positive	  cells	  were	  plated	  on	  a	  150-­‐mm	  plate	  (2	  µg/ml	  puromycin)	  and	  
left	   to	  grow	   for	  one	  week.	  The	  procedure	  was	   repeated	   two	  more	   times	  with	   seven	  days	  between	   the	  cycles,	  each	   time	  
using	  those	  cells	  for	  transfection	  that	  were	  FACS-­‐sorted	  the	  week	  before.	  After	  the	  cells	  were	  transfected	  and	  FACS-­‐sorted	  
for	  the	  third	  time,	  they	  were	  grown	  on	  a	  150-­‐mm	  plate	  (2	  µg/ml	  puromycin)	  until	  confluency	  and	  pooled	  for	  genomic	  DNA	  
isolation	  and	  insertion	  site	  analysis.	  	  	  
	  
Supplementary	  Note	  5	  
Insertion	  site-­‐	  and	  copy	  number	  analysis	  by	  splinkerette	  PCR	  
HeLa	   cell	   clones	  were	   grown	   until	   confluency	   on	   6-­‐well	   plates,	   washed	  with	   PBS	   and	   incubated	   overnight	   at	   55	  °C	  with	  
shaking	   in	   lysis	   buffer	   (100	  mM	   Tris	   pH	   8.0,	   5	  mM	   EDTA,	   0.2	   %	   SDS,	   200	  mM	   NaCl	   and	   100	  µg/µl	   proteinase	   K).	   HeLa	  
genomic	   DNA	   (gDNA)	   was	   isolated	   from	   lysed	   cells	   with	   standard	   phenol/chloroform	   extraction.	   Five	   μg	   of	   gDNA	   was	  
digested	  with	  FspBI	  for	  four	  hours	  followed	  by	  ethanol	  precipitation.	  In	  the	  next	  step,	  samples	  were	  ligated	  (300	  ng)	  to	  BfaI	  
splinkerette	  adapters	   (100	  pmol)	   in	  20	  μl	   reactions.	  Three	  microliters	  of	   the	   ligation	   reaction	  were	  used	   for	   the	   first	  PCR	  
with	  primers	   Linker	  primer	  and	  Hel1.	   The	   temperature	  profile	   for	   the	   first	  PCR	   round	  was:	  one	   cycle	  of	  94	   °C	   for	  3	  min,	  
followed	  by	  15	  cycles	  of	  94	  °C	  for	  30	  s,	  70	  °C	  for	  30	  s	  and	  72	  °C	  for	  30	  s;	  5	  cycles	  of	  94	  °C	  for	  30	  s,	  63	  °C	  for	  30	  s	  and	  72	  °C	  for	  
2	  s	  with	  an	  increase	  of	  2	  s	  per	  cycle;	  5	  cycles	  of	  94	  °C	  for	  30	  s,	  62	  °C	  for	  30	  s	  and	  72	  °C	  for	  12	  s	  with	  an	  increase	  of	  2	  s	  per	  
cycle;	  5	  cycles	  of	  94	  °C	  for	  30	  s,	  61	  °C	  for	  30	  s	  and	  72	  °C	  for	  22	  s	  with	  an	  increase	  of	  2	  s	  per	  cycle	  and	  5	  cycles	  of	  94	  °C	  for	  30	  
s,	  60	  °C	  for	  30	  s	  and	  72	  °C	  for	  30	  s.	  Nested	  PCR	  was	  performed	  with	  primers	  Nested	  and	  Hel2,	  and	  1	  μl	  	  of	  a	  1:100	  dilution	  of	  
the	  first	  PCR	  was	  used	  per	  50	  μl	  reaction.	  The	  temperature	  profile	  for	  the	  nested	  PCR	  started	  with	  a	  cycle	  of	  3	  min	  at	  94	  °C	  
followed	  by	  10	  cycles	  of	  94	  °C	  for	  30	  s,	  65	  °C	  for	  30	  s	  and	  72	  °C	  for	  30	  s	  and	  20	  cycles	  of	  94	  °C	  for	  30	  s,	  55	  °C	  for	  30	  s	  and	  72	  
°C	  for	  2	  min.	  The	  final	  elongation	  was	  performed	  for	  5	  min	  at	  72	  °C.	  
	   In	  order	  to	  analyze	  transposon-­‐genome	  junction	  sites	  at	  the	  3’-­‐terminus	  of	  the	  Helraiser	  insertions	  generated	  with	  
the	  pHelR,	   pHelRΔHP	  and	  pHelRΔRTS	   transposons,	   first	   left-­‐end	   splinkerette	  PCR	  was	  performed	  with	   the	   gDNA	   isolated	  
from	   HeLa	   clones	   to	   determine	   genomic	   locations	   of	   the	   transposon	   insertions.	   In	   the	   next	   step,	   specific	   primers	  
complementary	   to	   the	   genomic	   sequence	   located	   between	   50	   and	   100	   bp	   downstream	   from	   each	   transposon	   insertion	  
were	   designed	   (WT6a,	   WT6b,	   WT6c,	   WT6d,	   DelH2,	   DelH14,	   DelH19,	   DelRTS2,	   DelRTS15a),	   and	   used	   in	   genomic	   PCR	  
together	   with	   the	   HelCD1	   primer	   complementary	   to	   the	   sequence	   at	   the	   5’-­‐terminus	   of	   the	  Helraiser	   transposon.	   The	  
temperature	  profile	  for	  PCR	  was:	  95	  °C	  2	  min,	  followed	  by	  40	  cycles	  of	  95	  °C	  20	  s,	  57	  °C	  20	  s,	  72	  °C	  90	  s.	  The	  final	  elongation	  
step	  was	  performed	  at	  72	  °C	  5	  min.	  PCR	  products	  obtained	  in	  the	  genomic	  PCR	  were	  sequenced	  and	  analyzed.	  
	  
Supplementary	  Note	  6	  
Protein	  expression	  and	  purification	  
Cell	   pellets	   were	   resuspended	   in	   Nickel	   affinity	   column	   binding	   buffer	   (20	  mM	  NaH2PO4	   pH	   7.4,	   500	  mM	  NaCl,	   50	  mM	  
imidazole,	  1	  mM	  TCEP).	  All	  subsequent	  steps	  were	  performed	  at	  4	  °C.	  Lysis	  was	  done	  by	  incubating	  the	  cells	  on	  ice	  for	  30	  
minutes,	   then	  sonication	  with	  a	  Misonix	  Sonicator	  3000	   (5x	  20-­‐sec	  pulses	  with	  3	  minute	  pause	  at	  82	  Watts).	  The	  soluble	  
fraction	  was	  isolated	  by	  centrifugation	  at	  20,000	  x	  g,	  loaded	  onto	  a	  HiTrap	  CHeLating	  column	  (GE	  Healthcare)	  equilibrated	  in	  
Nickel	  affinity	  column	  binding	  buffer,	  and	  eluted	  using	  a	   linear	  gradient	  with	  elution	  buffer	   (20	  mM	  NaH2PO4	  pH	  7.4,	  500	  
mM	  NaCl,	  250	  mM	  imidazole,	  1	  mM	  TCEP).	  The	  eluted	  protein	  was	  dialyzed	  overnight	  in	  20	  mM	  NaH2PO4	  pH	  7.0,	  250	  mM	  
NaCl,	  1	  mM	  DTT	  and	  1mg/ml	  TEV	  protease	  added	  at	  1:100	  protease	  to	  protein	  volume	  ratio.	  The	  product	  was	  loaded	  onto	  a	  
HiTrap	  Heparin	  HP	  column	  (GE	  Healthcare)	  pre-­‐equilibrated	  with	  Heparin	  column	  binding	  buffer	  (20	  mM	  NaH2PO4	  pH	  7.0,	  
250	  mM	  NaCl,	  1	  mM	  TCEP),	  and	  eluted	  using	  a	  linear	  gradient	  with	  elution	  buffer	  (20	  mM	  NaH2PO4	  pH	  7.0,	  2	  M	  NaCl,	  1	  mM	  
TCEP).	  The	  Helraiser	   transposase	  was	   loaded	  on	  a	  HiLoad	  16/60	  Superdex	  200	  sizing	  column	  (GE	  Healthcare)	  equilibrated	  
with	  50	  mM	  HEPES	  pH	  7.5,	  150	  mM	  NaCl,	  0.5	  mM	  EDTA,	  1	  mM	  TCEP,	  and	   fractions	  containing	  the	  purified	  protein	  were	  
concentrated	   to	   10	   mg/ml.	   All	   point	   mutants	   were	   purified	   in	   the	   same	   manner,	   and	   exhibited	   no	   changes	   in	   either	  
expression	  or	  purification	  behavior	  (>90	  %	  homogeneity)	  from	  that	  of	  the	  wild-­‐type	  transposase.	  The	  same	  procedure	  was	  
also	  used	  to	  purify	  truncated	  versions	  of	  the	  transposase.	  
	  
Supplementary	  Note	  7	  
Cleavage	  assay	  and	  sequencing	  of	  cleavage	  products 
Cleavage	  was	  done	  at	  37	  °C	  for	  1	  hr,	  and	  quenched	  by	  addition	  of	  2	  μl	  Proteinase	  K	  (New	  England	  BioLabs)	  and	  2	  μl	  of	  0.5	  M	  
EDTA.	  For	  reactions	  with	  5	  mM	  MgCl2,	  reaction	  was	  done	  overnight	  at	  37	  °C.	  Proteinase	  K	  digestion	  was	  at	  45	  °C	  for	  30	  min,	  
after	  which	  an	  equal	  volume	  of	  loading	  dye	  (80	  %	  formamide,	  1	  mg/ml	  xylene	  cyanol,	  1	  mg/ml	  bromophenol	  blue,	  10	  mM	  
EDTA)	  was	   added	   and	   reactions	   incubated	   at	   22	   °C	   for	   15	  min,	   and	   then	   five	  min	   at	   95	   °C	   prior	   to	   gel	   loading	   on	   15	  %	  
Tris/Borate/EDTA/Urea	  gels	  (Invitrogen).	  The	  results	  were	  visualized	  using	  a	  Typhoon	  Trio	  (GE	  Healthcare).	  
	   Gels	  were	  stained	  with	  SYBR	  Safe	  DNA	  gel	  stain	  (Invitrogen),	  visualized	  by	  blue	  light,	  and	  each	  band	  cut	  out.	  	  ssDNA	  
extraction	  was	  done	  by	  crushing	  the	  gel	  and	  shaking	  overnight	  at	  37	  °C	  in	  Extraction	  Buffer	  (0.5	  N	  NH4Ac,	  10	  mM	  MgAc,	  1	  
mM	  EDTA,	  0.1%	  SDS).	  To	  remove	  any	  remaining	  contaminants,	  the	  solution	  was	  centrifuged	  at	  14,000	  x	  g	  for	  2	  min	  at	  4	  °C,	  
and	  the	  supernatant	  further	  cleaned	  of	  salts	  using	  an	  Illustra	  MicroSpin	  G-­‐25	  Columns	  (GE	  Healthcare).	  ssDNA	  	  was	  ligated	  
using	   ssDNA	   ligase	   kit	   (New	   England	   Biolabs)	   to	   the	   following	   oligonucleotide:	   5'-­‐
/5rApp/CAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTAAGCTTCC
AGCG/3SpC3/-­‐3'.	  Then	  using	  PCR	  and	  primers	  designed	  for	  the	  known	  part	  of	  the	  sequence	  of	  the	  5’	  end	  and	  reverse	  primer	  
to	   the	   above	   oligonucleotide,	   the	   fragment	  was	   amplified.	   The	   resulting	   dsDNA	  was	   cloned	   into	   pUC19	   using	  EcoRI	   and	  
HindIII	  restriction	  sites,	  and	  sequenced	  at	  the	  FDA-­‐FBR	  facility.	  
	  
Supplementary	  Note	  8	  
Protease	  digest	  and	  N-­‐terminal	  sequencing 
Helraiser	  transposase	  was	  diluted	  at	  1	  mg/ml	  in	  20	  µl	  of	  digestion	  buffer	  (50	  mM	  Hepes	  pH	  7.5,	  150	  mM	  NaCl,	  5	  mM	  MgCl2,	  
1	  mM	  TCEP),	  and	  a	  series	  of	  trypsin	  dilutions	  were	  added	  to	  final	  concentrations	  ranging	  from	  0.1-­‐1	  µg/µl.	  Samples	  were	  
incubated	   at	   37	   °C	   for	   1	   hr,	   and	   reactions	   quenched	  with	   NuPAGE	   loading	   dye	   (Novex)	   and	   boiling	   at	   95	   °C	   for	   5	  min.	  
Samples	  were	  then	  immediately	   loaded	  onto	  a	  4-­‐12	  %	  NuPAGE	  bis	  Tris	  gel	  (Novex).	  Bands	  were	  transferred	  to	  blot	  paper	  
using	  Invitrogen’s	  iBlot	  kit,	  and	  the	  sequence	  of	  each	  N-­‐terminal	  sequence	  was	  determined	  by	  the	  FDA-­‐FBR	  facility.	  
	  
Supplementary	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Colorimetric	  ATPase	  assay	   
ATP	   hydrolysis	  was	   analyzed	   by	  measuring	   the	   formation	   of	   free	   phosphate	   (Pi)	   as	   a	   function	   of	   time	   using	   procedures	  
adapted	  from	  Baykov	  et	  al.9.	  Helraiser	  transposase	  or	  mutant	  proteins	  were	  diluted	  to	  final	  concentrations	  between	  0.3-­‐1	  
μM	  in	  buffer	  containing	  50	  mM	  HEPES	  pH	  7.5,	  100	  mM	  NaCl,	  1	  mM	  DTT	  and	  2	  mM	  MgCl2	  and	  then	  heated	  to	  37	  °C	  for	  10	  
min.	   Reactions	   were	   initiated	   by	   the	   addition	   of	   ATP	   (Jena	   biosciences)	   to	   either	   a	   final	   concentration	   of	   1	   mM	   or	   a	  
concentration	  range	  between	  0.0078	  and	  1	  mM	  in	  a	  total	  volume	  of	  180	  µl.	  Samples	  (20	  µl)	  were	  removed	  at	  various	  time	  
points	  and	  immediately	  quenched	  in	  wells	  of	  a	  96-­‐well	  plate,	  each	  containing	  5	  μl	  of	  0.5	  M	  EDTA.	  An	  aliquot	  (150	  µl)	  of	  a	  1	  
mM	  malachite	  green	  stock	  solution	  was	  added	  to	  each	  well,	  and	  the	  absorbance	  at	  650	  nm	  was	  measured	  using	  a	  Molecular	  
Devices	  Spectramax	  M5	  microplate	  reader.	  The	  amount	  of	  phosphate	  released	  was	  calculated	  by	  comparison	  to	  a	  standard	  
curve	   generated	   using	   KH2PO4.	   DNA	   stimulation	   of	   ATP	   hydrolysis	   was	   measured	   using	   the	   same	   buffer	   and	   protein	  
concentration	  range	  (0.3,	  0.08,	  0.02	  mM),	  and	  ATP	  (1	  mM),	  but	  with	  the	  addition	  of	  1	  µM	  of	  either	  a	  50-­‐base-­‐long	  ssDNA	  or	  
50-­‐bp-­‐long	  dsDNA	  prior	  to	  the	  addition	  of	  ATP.	  Calculations	  of	  Km	  and	  kcat	  were	  done	  in	  EXCEL	  (Microsoft)	  and	  KaleidaGraph	  
4.0. 
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Integration	  site	  and	  fusion-­‐transcript	  library	  construction	  
The	  generation	  of	  the	  insertion	  site	  and	  fusion-­‐transcript	  libraries	  was	  based	  on	  a	  computation-­‐assisted	  hemi-­‐specific	  PCR	  
scheme.	  The	  PCR	  assays	  relied	  on	  the	  use	  of	  hemi-­‐specific	  primers10	  carrying	  only	  4	  specific	  nucleotides	  (4-­‐mers)	  at	  their	  3’-­‐
ends	   followed	   by	   random	   sequences	   and	   a	   specific	   overhang.	   These	   primers	   are	   to	   anneal	   to	   the	   neighborhood	   of	   the	  
transposon-­‐genome	  or	   transposon–genomic	   transcript	   junctions	  of	   the	   template	   genomic	  DNA,	  or	   cDNA,	   respectively,	   in	  
order	   to	   tag	   these	   loci	   for	   nested	   PCR	   amplifications.	   The	   4-­‐mers	   of	   the	   hemi-­‐specific	   primers	   were	   designed	  
computationally.	  Possible	  4-­‐mers	  were	   ranked	  by	   their	   representation	   in	   the	  human	  genome	  or	   transcriptome,	  excluding	  
those	  which	   could	   give	   rise	   to	   unwanted	   amplicons	   on	   the	   transposon	   sequences	   or	   on	   primer	   overhangs.	   Similarly,	   an	  
algorithm	  was	  implemented	  to	  predict	  the	  combination	  of	  those	  six	  4-­‐mers,	  which	  result	  in	  the	  most	  comprehensive	  library	  
for	  the	  human	  genome,	  or	  transcriptome,	  and	  the	  transposon	  vectors	  used.	  Next,	  multi-­‐step	  PCR	  schemes	  were	  performed	  
to	  obtain	  indexed,	  Illumina-­‐flow	  cell	  compatible	  fusion	  transcriptome,	  or	  integrome	  libraries.	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Insertion-­‐library	  preparation	  and	  high-­‐throughput	  sequencing	  of	   integration	  sites	  of	  Helitron	  transposons	  in	  the	  human	  
genome	  
300	  ng	  of	  gDNA	  isolated	  from	  pools	  of	  puromycin-­‐resistant	  HeLa	  colonies	  were	  used	  as	  template	  for	  the	  initial	  6	  parallel	  PCR	  
reactions,	  containing	  6	  different	  hemi-­‐specific	  primers,	  with	  the	  following	  conditions:	  for	  the	  5’	  Helitron	  transposon	  end:	  95	  
oC	  1	  min,	  40	  cycles	  of	  (94	  oC	  30	  s,	  65	  oC	  30	  s,	  72	  oC	  30	  s),	  2	  cycles	  of	  (94	  oC	  30	  s,	  25	  oC	  1	  min,	  ramp	  to	  72	  oC	  at	  0.2	  oC/s,	  72	  oC	  1	  
min)	  with	  5	  pmol	  of	  Hel_Lft_1	  specific	  for	  the	  5’-­‐Helitron	  sequence	  or	  5	  pmol	  of	  Hel_3P_1	  for	  the	  3’-­‐transposon	  end	  with	  
the	  same	  program	  but	  with	  62	   oC	  annealing	   temperature.	  The	   first	  PCR	  reactions	  were	  supplemented	  with	  25	  µls	  of	  PCR	  
master	  mix	   containing	   15	   pmol	   of	   Hel_Lft_2	   for	   the	   5’-­‐	   and	   Hel_3P_2	   for	   the	   3’-­‐transposon	   end,	   respectively.	   The	   PCR	  
program	  for	  the	  5’-­‐end	  was:	  15	  super-­‐cycles	  of	  [3	  cycles	  of	  (94	  oC	  30	  s,	  65	  oC	  30	  s,	  72	  oC	  40	  s)	  1	  cycle	  of	  (94	  oC	  30	  s,	  60	  oC	  30	  s,	  
72	  oC	  40	  s)].	  For	  the	  3’-­‐end	  62	  oC	  annealing	  temperature	  was	  used	  for	  the	  3	  cycles.	  The	  PCR	  products	  were	  column-­‐purified	  
and	  2	  µls	  of	  the	  30	  µl	  elutes	  were	  used	  for	  the	  1st	  exponential	  PCRs,	  with	  the	  primer	  PE_first	  and	  Hel_L_bc	  for	  the	  5’-­‐	  and	  
Hel_3P_bc	  for	  the	  3’-­‐transposon	  ends,	  respectively,	  using	  the	  following	  cycling	  conditions:	  95	  oC	  30	  s,	  20	  cycles	  of	  94	  oC	  30	  s,	  
65	  oC	  30	  s,	  72	  oC	  1	  min.	  For	  the	  3’-­‐transposon	  end	  the	  annealing	  temperature	  was	  58	  oC.	  1	  µl	  10x	  diluted	  1st	  exponential	  PCR	  
products	  were	  used	  to	  add	  Illumina	  adaptors	  to	  the	  amplicons	  using	  Pfx	  polymerase	  (Life	  Technologies)	  with	  these	  cycling	  
conditions:	  95	  oC	  30	  s,	  20	  cycles	  of	  94	  oC	  15	  s,	  68	  oC	  1	  min.	  The	  final	  PCR	  products	  were	  run	  on	  agarose	  gels	  and	  amplicons	  
between	   200	   and	   500	   bp	   were	   excised	   and	   column-­‐purified	   (Zymoclean	   Gel	   DNA	   Recovery	   Kit,	   Zymo	   Research).	   The	  
sequencing	  of	  the	  resulting	  libraries	  was	  carried	  out	  on	  Illumina	  HiSeq	  2500	  instruments	  at	  the	  Beckman	  Coulter	  Genomics	  
Danvers	  Massachusetts	  USA	  sequencing	  facility.	  
	   The	   raw	   reads	   were	   processed	   for	   mapping	   as	   follows.	   Primer-­‐,	   transposon-­‐,	   and	   right	   Illumina	   adapter-­‐related	  
sequences	  were	  trimmed.	  The	  resulting	  reads	  were	  quality	  filtered	  by	  omitting	  reads	  containing	  ‘N’	  bases	  and	  by	  trimming	  
reads	  as	  soon	  as	  2	  of	  5	  bases	  has	  quality	  encoding	  less	  than	  phred	  score	  20.	  All	  trimmed	  reads	  shorter	  than	  24	  bases	  were	  
dropped.	  The	  remaining	  sequences	  were	  mapped	  against	  the	  h19	  human	  genome	  assembly	  with	  Bowtie11.	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Detection	  of	  NUBPL	  promoter-­‐driven	  fusion	  transcripts	  	  
500	   ng	   of	   total	   RNA	   purified	   from	   puro	   resistant	   HeLa	   colonies	   were	   reverse-­‐transcribed	   using	   Maxima	   Reverse	  
Transcriptase	  (Thermo	  Scientific)	  and	  oligo	  dT	  primers	  at	  50	  oC	  for	  30	  min.	  After	  heat-­‐inactivation	  the	  reverse-­‐transcription	  
reaction	  was	  repeated.	  The	  RNA	  was	  hydrolyzed	  with	  one-­‐fifth	  volume	  of	  1	  N	  NaOH	  and	  0.5	  M	  EDTA	  at	  65	  oC	  for	  15	  min.	  
The	   cDNA	   was	   purified	   with	   DNA	   Clean	   &	   Concentrator	   Kit	   (Zymo	   Research)	   and	   2	   µl	   of	   the	   elute	   was	   used	   for	   6	  
independent	  PCR	  amplifications	  with	  the	  following	  conditions:	  95	  oC	  1	  min,	  40	  cycles	  of	  (94	  oC	  30	  s,	  65	  oC	  30	  s,	  72	  oC	  30	  s),	  2	  
cycles	  of	   (94	  oC	  30	  s,	  25	  oC	  1	  min,	   ramp	  to	  72	  oC	  at	  0.2	  oC/s,	  72	  oC	  1	  min)	  with	  the	  primer	  Puro1	  specific	   for	   the	  Helitron	  
vector	  sequence	  and	  4-­‐mer	  hemi-­‐specific	  primers	  computationally	  predicted	  for	  high	  representation	  on	  the	  entire	  human	  
transcriptome.	  The	  first	  PCR	  reaction	  was	  supplemented	  with	  25	  µls	  of	  PCR	  master	  mix	  containing	  the	  vector	  specific	  oligo	  
Puro2	  to	  perform	  the	  subsequent	  asymmetric	  PCR	  reaction	  with	  the	  following	  condition:	  10	  super-­‐cycles	  of	  [3	  cycles	  of	  (94	  
oC	  30	  s,	  65	  oC	  30	  s,	  72	  oC	  40	  s)	  1	  cycle	  of	  (94	  oC	  30	  s,	  60	  oC	  30	  s,	  72	  oC	  40	  s)].	  The	  PCR	  products	  were	  column-­‐purified	  and	  2	  µl	  
of	  the	  30	  µl	  elute	  were	  used	  for	  the	  1st	  exponential	  PCR,	  with	  the	  transposon-­‐specific	  oligo	  T2a_SD_bc	  and	  PE_first	  specific	  
for	   the	   overhang	   of	   the	   hemi-­‐specific	   primers.	   The	   PCR	   products	  were	   purified	   and	   TA-­‐cloned	   using	   the	   pGEM-­‐T	  Vector	  
System	  (Promega)	  and	  sequenced.	  Fusion	  transcripts	  were	  determined	  by	  aligning	  the	  sequences	  following	  the	  splice	  donor	  
site	  within	  the	  Helitron	  transposon	  with	  the	  BLAT	  tool	  of	  the	  UCSC	  genome	  browser.	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Helraiser	  insertion	  site	  analysis	  
We	   identified	  1751	   independent	   integration	  events.	  For	  statistical	  analysis,	  we	  created	  sets	  of	   randomly	  chosen	  genomic	  
sites	  according	  to	  two	  different	  background	  models.	  The	  model	  (‘random’)	  is	  normalized	  relative	  the	  abnormal	  karyotype	  of	  
HeLa	   cells.	   The	   second	   model	   (‘control’)	   also	   accounts	   for	   the	   mappability	   of	   sequencing	   reads	   and	   imitates	   the	   base	  
composition	  at	  integration	  sites.	  To	  determine	  the	  karyotype	  of	  HeLa	  cells,	  we	  used	  ChIP-­‐Seq	  input	  data	  sets	  generated	  by	  
the	   Broad/MGH	   ENCODE	   group.	   Since	   these	   data	   sets	   were	   generated	   without	   the	   application	   of	   specifically	   binding	  
antibodies,	  the	  read	  densities	  can	  be	  used	  as	  estimates	  for	  the	  relative	  copy	  numbers	  of	  the	  underlying	  genomic	  regions.	  
Mapped	  sequencing	  reads	  of	  two	  biological	  replicates	  for	  HeLa	  cells	  as	  well	  as	  for	  12	  other	  cell	  types	  with	  normal	  karyotype	  
were	   downloaded	   from	   the	   UCSC	   Genome	   Bioinformatics	   web	   site	   (http://genome.ucsc.edu/cgi-­‐
bin/hgFileUi?db=hg19&g=wgEncodeBroadHistone).	  	  We	  computed	  for	  each	  data	  set	  pair	  of	  HeLa	  cells	  and	  normal	  cells	  the	  
fold	  changes	  of	  the	  read	  counts	  in	  sliding	  windows	  each	  covering	  1000	  consecutive	  reads	  from	  the	  normal	  cell	  data	  set.	  The	  
resulting	   fold	   changes	  were	  multiplied	   by	   the	   assumed	   average	   ploidy	   of	  HeLa	   cells	   (i.e.	   3)	   and	   divided	   by	   ploidy	   of	   the	  
normal	  cells	  (i.e.	  2	  for	  non-­‐sex	  chromosomes,	  and	  chrX	  and	  chrY	  depending	  on	  the	  gender	  of	  the	  control	  cell	  data	  set),	  then	  
smoothed	  with	  a	  running	  median	  filter	  of	  window	  size	  30000,	  and	  finally	  rounded	  to	  the	  closest	  integer	  value.	  The	  results	  
from	  all	  pairs	  of	  HeLa	  cell	   and	  normal	   cell	  data	   sets	  were	   then	   joined	  by	  computing	  medians.	  Tested	  on	  data	  originating	  
from	   normal	   cells,	   the	   method	   correctly	   predicted	   normal	   karyotypes	   (data	   not	   shown).	   For	   the	   ‘random’	   background	  
model	  we	  sampled	  500000	  random	  positions	  in	  the	  genome	  in	  a	  way	  that	  the	  probability	  for	  choosing	  a	  genomic	  position	  is	  
proportional	  to	  the	  ploidy	  of	  its	  chromosomal	  fragment.	  The	  ‘control’	  background	  model	  was	  generated	  as	  follows.	  First	  we	  
sampled	  100	  million	  random	  genomic	  positions	  in	  a	  way	  that	  the	  probability	  for	  choosing	  a	  genomic	  position	  is	  proportional	  
to	   the	   ploidy	   of	   its	   chromosomal	   fragment.	   From	   these	   positions	   we	   sampled	  mock	   sequencing	   reads	   having	   the	   same	  
length	   distribution	   as	   the	   real	   sequencing	   reads	   mapped	   at	   transposon	   integration	   sites.	   The	   mock	   reads	   were	   then	  
processed	  as	  the	  sequencing	  reads	  described	  before.	  The	  resulting	  mock	  sites	  were	  scored	  using	  a	  position	  specific	  weight	  
matrix	   (PWM)	   derived	   from	   base	   composition	   at	   integration	   sites	   (Fig.	   5A).	   From	   the	   mock	   sites	   we	   sampled	   100,000	  
control	  sites	  in	  a	  way	  that	  their	  PWM	  score	  distribution	  resembled	  the	  PWM	  score	  distribution	  of	  the	  real	  integration	  sites.	  
The	  information	  about	  gene	  expression	  levels,	  histone	  modifications	  and	  chromatin	  accessibility,	  and	  the	  genomic	  locations	  
of	   CpG	   islands	   and	   lamina	   associated	   domains	   was	   downloaded	   from	   UCSC	   (http://genome.ucsc.edu).	   Open	   chromatin	  
regions	  are	  derived	  from	  DNaseI	  HS	  data,	  FAIRE	  data	  and	  ChIP	  data,	  validated	  regions	  taken	  from	  the	  UCSC	  Open	  Chrom	  
Synth	  track,	  release	  2	  (Feb	  2012).	  
	  
Supplementary	  Note	  14	  
Analysis	  of	  3’-­‐ends	  of	  recently	  active	  Helitrons	  in	  Myotis	  genomes	  
To	  understand	  the	  pattern	  of	  acquisition	  of	  de	  novo	  ends	  by	  Helitrons	   in	  sequenced	  genomes,	  we	  analyzed	  the	  copies	  of	  
three	  Helibat	  exemplars	  (HelibatN541,	  HelibatN542	  and	  HelibatN580)	  in	  the	  Myotis	  lineage.	  The	  copies	  were	  recently	  active	  
(98-­‐99	  %	  identical	  to	  the	  consensus),	  which	  minimizes	  the	  impact	  of	  selection	  on	  how	  the	  sequence	  signature	  is	  interpreted.	  
The	  HelibatN541	  copies	  are	  unique	  to	  the	  M.	  lucifugus	   lineage5,	  the	  HelibatN580	  copies	  unique	  to	  the	  M.	  brandtii	   lineage	  
and	   the	  HelibatN542	   copies	  are	   found	   in	  both	   lineages.	  Copies	  of	  Helibat	   exemplars	   (HelibatN541	   and	  HelibatN580)	   that	  
were	  98-­‐99	  %	  identical	  to	  the	  consensus	  were	  extracted	  from	  their	  respective	  genomes.	  The	  HelibatN542	  copies	  that	  were	  
>95	   %	   identical	   to	   the	   consensus	   and	   have	   intact	   5’-­‐ends	   were	   extracted	   from	   the	   M.	   lucifugus	   genome.	   Since	   the	  
HelibatN542	  copies	  are	  comparatively	  older,	  we	  used	  a	  different	  cut	  off.	  The	  last	  30	  bp	  of	  each	  copy	  were	  aligned	  to	  their	  
respective	  consensus	  using	  MUSCLE12.	  The	  copies	  that	  have	  ends	  that	  are	  >20	  %	  diverged	  from	  the	  consensus	  or	  that	  do	  not	  
align	   (de	   novo)	   were	   carefully	   analyzed	   using	   homology-­‐based	   tools	   (BLAST	   tools13)	   to	   gain	   insights	   into	   the	   origin	   and	  
evolution	  of	  the	  3’-­‐end.	  We	  also	  employed	  a	  comparative	  genomics	  approach	  using	  other	  bat	  whole	  genome	  sequences	  to	  
exclude	  false	  positives.	  For	  example,	  if	  a	  copy	  in	  one	  bat	  genome	  has	  a	  de	  novo	  3’-­‐end	  and	  the	  orthologous	  copy	  has	  an	  end	  
homologous	  to	  the	  consensus,	  then	  those	  changes	  were	  presumed	  to	  have	  occurred	  post	  insertion.	  In	  addition,	  empty	  sites	  
(insertion-­‐free	  sites)	  were	  used	  to	  confirm	  the	  boundaries	  of	  the	  element.	  	  
	  
Supplementary	  Note	  15	  
Annotation	  of	  Helitrons	  (coordinates,	  approximate	  age,	  and	  relative	  orientation)	  in	  the	  M.	  brandtii	  genome	  	  
Helitron	   insertions	   were	   identified	   (RepeatMasker	   v.4.0.5	   http://www.repeatmasker.org)	   in	   the	   M.	   brandtii	   genome	  
assembly	  (KE161034-­‐KE332376,	  171343	  scaffolds	  from	  GenBank	  at	  National	  Center	  for	  Biotechnology	  Information	  (NCBI)14	  
using	   a	   Myotis-­‐specific	   Helitron	   repeat	   library	   previously	   described5.	   Conservation	   of	   the	   Helitron	   insertions	   were	  
determined	  by	  taking	  the	  Helitron	  DNA	  sequence	  plus	  200	  bp	  flanking	  sequence	  and	  performing	  a	  blastn	  query	  of	  the	  NCBI	  
wgs	  database	  to	  determine	   if	   the	   insertion	  was	  present	   in	  other	  sequenced	  Vespertilionidae	  bats	   (E.	   fuscus,	  M.	   lucifugus,	  
and	  M.	  davidii).	  If	  there	  was	  a	  hit	  to	  the	  entire	  length	  of	  the	  query	  sequence	  in	  a	  given	  species,	  it	  was	  considered	  present	  
(conserved)	   in	   that	   species.	   If	   there	  was	  only	  a	  hit	   to	   the	  Helitron	  or	  no	  hit,	   it	  was	  considered	  absent.	  By	  combining	   this	  
information	  with	  the	  known	  divergence	  times	  of	  the	  bats,	  we	  obtained	  an	  approximate	  age	  for	  each	  insertion.	  To	  determine	  
if	  there	  was	  a	  bias	  in	  the	  orientation	  of	  Helitrons	   inserting	  into	  gene	  models,	  we	  used	  a	  pipeline	  previously	  described15	  to	  
identify	  Helitrons	  either	  overlapping	  with	  introns,	  exons,	  or	  in	  regions	  1	  kb	  up	  or	  downstream	  of	  an	  annotated	  gene	  model.	  
Both	  Helitrons	   that	   inserted	   in	   the	   same	   orientation	   and	   opposite	   orientation	   as	   their	   target	   gene	  were	   quantified,	   and	  
compared	  using	  a	  2-­‐tailed,	  2-­‐sample	  T-­‐test,	  α	  =	  0.05.	  
	  
Supplementary	  Note	  16	  
M.	  brandtii	  transcriptome	  assembly,	  alternative	  splicing	  analysis,	  abundance	  estimation,	  and	  gene	  assignment	  
M.	   brandtii	   was	   used	   for	   these	   analyses,	   because	   numerous	   high	   quality	   directional	   RNA-­‐seq	   with	   high	   coverage	   are	  
publically	   available	  and	   the	  genome	  contains	  ~2000	  Helitron-­‐captured	  NUBPL	   insertions.	   Ilumina	  RNA-­‐seq	   reads	   (200	  bp,	  
paired)	   from	   the	   kidney,	   liver,	   and	   brain	   tissues	   of	   M.	   brandtii	   (SRA061140)14	   were	   pooled,	   quality-­‐trimmed	   using	  
Trimmomatic16,	  and	  assembled	  (de-­‐novo	  and	  genome-­‐guided)	  using	  Trinity	  (r2014041317,	  18).	  	  The	  resulting	  assemblies	  from	  
the	   two	   analyses	   were	   combined	   and	   alternative	   splicing	   analysis	   was	   performed	   using	   Program	   to	   Assemble	   Spliced	  
Alignments	  (PASA_r20140417)18,	  19,	  20.	  The	  relative	  abundance	  of	  each	  transcript	  (FPKM)	  was	  determined	  using	  RNA-­‐Seq	  by	  
Expectation-­‐Maximization	  (RSEM;	  v.1.2.12)21.	  Transcripts	  lacking	  splicing	  information	  (and	  thus	  directionality	  information),	  
abundance	   of	   FPKM	   <0.5,	   and	   total	   length	   <200	   bp	  were	   removed	   from	   the	   assembly,	   resulting	   in	   the	   final	  M.	   brandtii	  
transcriptome	  assembly.	  Transcripts	  were	  assigned	  to	  genes	  by	  intersecting	  genomic	  coordinates	  with	  the	  current	  genome	  
annotation	  (Bedtools;	  v.2.22.122)	  and	  by	  verifying	  homology	  to	  known	  transcripts	  of	  that	  gene	  using	  BLAST.	  Coding	  potential	  
for	  each	  transcript	  was	  determined	  as	  having	  a	  predicted	  ORF	  >100	  amino	  acids18.	  Tissue	  specificity	  for	  each	  transcript	  was	  
also	  determined,	  and	  a	  transcript	  was	  considered	  to	  be	  tissue	  specific	  if	  its	  FPKM	  value	  was	  >0.5	  in	  only	  one	  or	  two	  of	  the	  




Supplementary	  Note	  17	  
Identifying	  Helitron-­‐captured	  NUBPL	  promoter	  (NUBPL-­‐HCP)	  driven	  transcripts	  in	  M.	  brandtii	  
The	  genomic	  coordinates	  of	  Helitrons	  containing	  the	  captured	  NUBPL	  promoter	  were	   intersected	  with	  the	  coordinates	  of	  
the	  assembled	  transcripts.	  We	  used	  stringent	  criteria	  to	  ensure	  that	  the	  transcript	  was	  detectable	  (FPKM	  >0.5),	  that	  it	  had	  
strand-­‐specificity,	  and	   that	   the	  NUBPL	  promoter	   itself	  was	  within	  1	  kb	  upstream	  of	   the	  TSS23.	  Transcripts	  with	  an	  NUBPL	  
promoter-­‐containing	  Helitron	  located	  were	  classified	  as	  candidate	  NUBPL-­‐HCP	  driven	  transcripts.	  Transcripts	  whose	  TSS	  was	  
provided	  by	  the	  NUBPL	  promoter-­‐containing	  Helitron	  were	  considered	  to	  be	  authenticated	  NUBPL-­‐HCP	  driven	  transcripts.	  
Those	  genes	  that	  had	  at	  least	  one	  transcript	  putatively	  driven	  by	  a	  Helitron	  were	  included	  in	  a	  GO	  Term	  Analysis	  Enrichment	  
Analysis	  and	  terms	  were	  considered	  significant	  if	  their	  p-­‐values	  were	  less	  than	  0.0524,	  25. Each	  NUBPL	  promoter	  within	  1	  kb	  
of	   the	   TSS	   of	   a	   transcript	   with	   FPKM	   >	   0.5	   was	   analyzed	   for	   promoter	  motifs	   such	   as	   TATA,	   CAAT,	   and	   GC	   boxes,	   and	  
predicted	  transcription	  factor	  (TF)	  binding	  sites	  using	  GPMiner26.	  
	  
Supplementary	  Note	  18	  
Determining	  enrichment/depletion	  of	  Helitrons	  in	  M.	  brandtii	  in	  regions	  +/-­‐	  1	  kb	  to	  transcription	  start	  sites	  (TSS)	  
To	  obtain	  coordinates	  corresponding	  to	  a	  2-­‐kb	  interval	  centered	  on	  the	  TSSs	  of	  M.	  brandtii	  genes,	  we	  extracted	  coordinates	  
for	  -­‐1	  kb	  and	  +1	  kb	  relative	  to	  the	  TSSs	  from	  our	  M.	  brandtii	  gene	  assemblies.	  We	  then	  intersected	  these	  coordinates	  with	  
those	  of	  known	  Helitron	  insertions	  in	  M.	  brandtii	  (RepeatMasker,	  see	  above)	  using	  Bedtools,	  and	  determined	  enrichment	  or	  
depletion	  via	  Fisher’s	  Exact	  test	  (α	  =	  0.05)22.	  Results	  were	  considered	  significant	  if	  the	  two-­‐tailed	  p-­‐value	  was	  <	  0.05,	  and	  the	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